Shell Asset Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Shell Asset Management’s Portfolio SCLN Stock Details SCLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-102,502	Closed	-$943K	–	919
2015 Q4	$943K	Sell	102,502 -6,411	-6%	-$53.7K	0.02%	567
2015 Q3	$750K	Buy	108,913 +5,079	+5%	+$43.5K	0.01%	731
2015 Q2	$1.02M	Sell	103,834 -4,759	-4%	-$43.3K	0.02%	593
2015 Q1	$962K	Sell	108,593 -320	-0.3%	-$2.55K	0.02%	634
2014 Q4	$954K	Hold	108,913	–	–	0.02%	711
2014 Q3	$750K	Buy	108,913 +10,162	+10%	+$60.9K	0.01%	756
2014 Q2	$519K	Buy	+98,751	New	+$481K	0.01%	801

Other funds holding SCLN

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sensato Investors San Francisco, California $122M AUM 5.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Shell Asset Management's SCLN Position: Q1 2016 in Review

Shell Asset Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q1 2016, closing a stake of 102,502 shares — an estimated $943K sold.

Shell Asset Management first reported a position in SCLN in Q2 2014 and held it in 7 quarters. The position peaked at $1.02M in Q2 2015. 142 funds tracked by Wall St. Rank hold SCLN as of Q1 2016.

Shell Asset Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q1 2016 after selling out during the quarter.
Shell Asset Management sold 102,502 Sciclone Pharmaceuticals Inc shares in Q1 2016, an estimated $943K.
Shell Asset Management first reported a position in Sciclone Pharmaceuticals Inc in Q2 2014 and held it in 7 quarters.
Shell Asset Management's Sciclone Pharmaceuticals Inc position peaked at $1.02M in Q2 2015.
142 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q1 2016.

Based on Shell Asset Management's 13F filing for Q1 2016, filed 11 May 2016.